ARCHIVES

Phase III Kyprolis Trial Fails OS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Congressional Action Imminent On Cancer Ac Renewal, Hew Money Bills; Veto Threatened

September 8, 1978

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

November 8, 2013

Study Finds More Deaths On Aranesp Arm In Cancer Anemia Study, No Benefit Seen.

February 2, 2007

Panel Debates Whether DCIS Needs A New Name

September 25, 2009

NIH funds eight centers for health disparities research.

October 10, 2003

Final NIH ethics rules retain consulting ban, but limit divesture requirement to senior employees.

September 9, 2005